Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by Dandy07on Jun 12, 2020 2:12pm

265 Views

Post# 31144389

Lvl II

Last:

0.045

Change:

-0.005

Volume:

257,000

Last Trade:

13:21

Level ll Quote
Bid			Ask
Price	Total Size	# of Orders	Price	Total Size	# of Orders

$0.045	258000	2	$0.05	578000	11
$0.04	4797000	37	$0.055	418000	14
$0.035	2081000	24	$0.06	318000	8
$0.03	1314000	19	$0.065	389000	8
$0.025	700000	13	$0.07	471000	8
$0.02	480000	11	$0.075	195000	5
$0.015	301000	5	$0.08	601000	11
$0.01	500000	1	$0.085	179000	3
			$0.09	280000	4
			$0.095	101000	3